Moleculin Biotech Inc (NASDAQ:MBRX)’s traded shares stood at 1.27 million during the last session, with the company’s beta value hitting 1.95. At the close of trading, the stock’s price was $0.84, to imply a decrease of -15.27% or -$0.15 in intraday trading. The MBRX share’s 52-week high remains $10.35, putting it -1132.14% down since that peak but still an impressive -15.48% since price per share fell to its 52-week low of $0.97. The company has a valuation of $2.84M, with an average of 74880.0 shares in intraday trading volume over the past 10 days and average of 64.03K shares over the past 3 months.
Moleculin Biotech Inc (NASDAQ:MBRX) trade information
After registering a -15.27% downside in the last session, Moleculin Biotech Inc (MBRX) has traded red over the past five days. The 5-day price performance for the stock is -45.43%, and -53.05% over 30 days. With these gigs, the year-to-date price performance is -50.56%. Short interest in Moleculin Biotech Inc (NASDAQ:MBRX) saw shorts transact 0.17 million shares and set a 2.62 days time to cover.
Moleculin Biotech Inc (MBRX) estimates and forecasts
Looking at statistics comparing Moleculin Biotech Inc share performance against respective industry, we note that the company has outperformed competitors. Moleculin Biotech Inc (MBRX) shares are -61.80% down over the last 6 months, with its year-to-date growth rate higher than industry average at 96.63% against 15.90%.
MBRX Dividends
Moleculin Biotech Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders
Moleculin Biotech Inc insiders hold 3.34% of total outstanding shares, with institutional holders owning 15.33% of the shares at 15.87% float percentage. In total, 15.33% institutions holds shares in the company.
